# Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Kidney Transplant Recipients

> **NCT02083042** · — · COMPLETED · sponsor: **Lophius Biosciences GmbH** · enrollment: 97 (actual)

## Conditions studied

- Cytomegalovirus
- Kidney Transplantation
- CMV Specific Immune Response

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02083042
- **Lead sponsor:** Lophius Biosciences GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2015-10
- **Final completion:** 2015-12
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2016-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02083042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02083042, "Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Kidney Transplant Recipients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02083042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*